NANCY COCCHIARELLA: Open Payments
NPI 1295994069 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 21 payments from 11 companies in 2025. Trend: 2023 $875 · 2024 $336 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $179 |
| Sage Therapeutics, LLC | 2 | $51 |
| Dexcom, Inc. | 2 | $50 |
| PFIZER INC. | 2 | $44 |
| ABBVIE INC. | 2 | $36 |
| Exeltis, USA Inc. | 1 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: Veozah, ZURZUVAE, Dexcom G6 Transmitter, COMIRNATY, LILETTA, SLYND, Exparel, GEMTESA.
Industry payments across RI — which companies pay providers there.
